SANOFI
Sanofi
: The arrival of the ‘ haute couture ’ supply chain
defining a protocol , defining the way in which the study will be carried out , and the way that the data will be managed .
“ The main thing that the patient will see when they are included in a Sanofi clinical trial will be the treatment . The patient will see the investigator , the physician and the hospital staff who will take care of them , but no one from Sanofi ,” said Dourlens .
Yet , the treatment that the patients will get – when they receive a box of drugs or vaccine designed to either save or vastly improve their life – comes from Sanofi . It ’ s Dourlens ’ team ’ s job to get the drug to the patient on time , whatever the situation .
“ We have been experimenting with our supply chain for years , during both the COVID-19 pandemic and Russia ’ s invasion of Ukraine ,” says Dourlens . “ We were still able to continue to supply almost everywhere during the pandemic .”
So , how did managing the COVID-19 clinical supply chain compare to supporting it after Russia ’ s invasion of Ukraine ?
“ Many patients have been in a terrible situation due to the war , but even more so when expecting a life-saving drug that it isn ’ t possible to receive .”
66 February 2023